Leveraging data for better patient outcomes
Leveraging data for better patient outcomes. Chris Moore, President at Veeva Systems discusses how a connected and collaborative healthcare ecosystem will drive innovation and...
Reality check: The challenges of digital health
Hassan Chaudhury, Digital Health Lead, Healthcare UK, Department for International Trade, looks at the challenges of digital health and why pharma should bet big...
Pharma sales models for HCP engagement: From digitally naive to native
Pharma sales models for HCP engagement are changing quickly and indefinitely, and for businesses in the sector, Mick O'Leary of Ashfield says it’s a...
How bioelectronic medical devices are transforming modern healthcare
Bernard Ross, Chief Executive Officer and founder of Sky Medical Technology explores how innovative bioelectronic medical devices are transforming modern healthcare. Every 37 seconds someone in...
Improving customer experience with AI and machine learning
Improving customer experience with AI and machine learning. Richard Gray of IQVIA says it’s all in the mind(set). This year marks an inflection point...
Could blockchain reduce NHS clinical negligence claims?
Dr Amina Albeyatti of MyClinic asks whether blockchain could reduce clinical negligence claims against the NHS. The NHS is one of the best healthcare systems...
GPs and pharmacists are using virtual clinics in primary care
Dr Zubair Ahmed, Co-founder and CEO of Medicspot, looks at how GPs and pharmacists are using virtual clinics in primary care. Since founding Medicspot four...
Embracing AI in pharma sales
The future of pharmaceutical sales will rely increasingly on the combination of technology and data. Rasim Shah, Director of OKRA discusses embracing AI in pharma...
The five trends of a digital pharma future
Neil Osmond, Technologist and Founder of earthware, explores the five trends of a digital pharma future. Human and digital must work together to benefit...
Reducing animal use in biopharmaceuticals
EU directives and animal welfare initiatives keep challenging scientists and industry leaders to change conventional practices. Far from hindering scientific and technological progress, this...
Latest articles
Reputation control: changing perceptions of pharma
Amanda Barrel investigates pharma’s reputation, self-regulation, compliance and how pharma can change perceptions of the work it does. Top 5 Takeaways
1 Only 57% of people...
Medicines and Medical Devices Bill: Getting it right for all
With the Medicines and Medical Devices Bill heading through Parliament, Claudia Rubin asks what is required to get this legislation right? The Government would like...
Popular articles
NICE guidelines on active management of patients with COVID-19
The National Institute for Health and Care Excellence (NICE) has published its first three rapid guidelines on the active management of patients with COVID-19...
FDA emergency authorisation for Roche’s COVID-19 test
Roche has announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its COVID-19 test, the cobas®...
UPDATED: MHRA guidance on coronavirus (COVID-19)
The MHRA is producing guidance on coronavirus (COVID-19) for industry. The Medicines and Healthcare products Regulatory Agency (MHRA) is working closely with Department of Health...
Looking for a breakthrough in Parkinson’s research
Will recent investments and developments offer hope for people living with Parkinson’s? Pf explores the condition and work happening to find a breakthrough in...
Does NICE hold the cards to drug pricing and reimbursement?
The upcoming NICE Methods Review begs the question: at what price does a drug represent value for money to the NHS? Rebecca Lanning discusses...